C4 Therapeutics, Inc.

Ownership Transactions Reported by 22 Insiders

Symbol
CCCC on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
490 Arsenal Way, Suite 120, Watertown, Massachusetts

There are no Buy or Sell transactions made by insiders since 7/8/2023

C4 Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Alain J. Cohen Director $11.8 M Apr 4, 2022
Glenn Dubin Director $6.58 M Apr 1, 2024
Elena Prokupets Director $3.49 M Sep 27, 2021
Andrew Hirsch President & CEO, Director $1.66 M Feb 15, 2024
Kenneth Carl Anderson Director $1.54 M Jul 1, 2024
Stewart Fisher Chief Scientific Officer $843 K Mar 7, 2024
Leonard Reyno Chief Medical Officer $640 K Feb 14, 2024
Kendra Adams Chief Financial Officer $536 K Mar 7, 2024
Scott N. Boyle Chief Business Officer $342 K Mar 7, 2024
Kelly Schick Chief People Officer $341 K Mar 7, 2024
Jolie Siegel Chief Legal Officer $341 K Mar 7, 2024
Lauren White Chief Financial Officer $213 K Aug 30, 2023
Mark Mossler Chief Accounting Officer $160 K Feb 14, 2024
Adam Crystal Chief Medical Officer $131 K Jan 30, 2023
Donna Roy Grogan Director $128 K Jul 1, 2024
Laura Bessen Director Jun 20, 2024
Owen Hughes Director Jun 20, 2024
Bruce Downey Director Jun 20, 2024
Marc A. Cohen Director Jun 22, 2022
Utpal Koppikar Director Jun 20, 2024
Ronald Harold Wilfred Cooper Director Jun 7, 2024
Malcolm Salter Director Jun 20, 2024

Recent Insider Transactions by Companies or Individuals for C4 Therapeutics, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership